Quest Diagnostics (DGX) Enterprise Value (2009 - 2026)

Quest Diagnostics has reported Enterprise Value for 18 years, with the latest figure at -$323.0 million in Q2 2026.

• Quarterly Enterprise Value fell 35.71% year-over-year to -$323.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$323.0 million (down 35.71% YoY) and the FY2025 annual result came in at -$340.0 million, up 27.04% from the prior year.
• Enterprise Value declined to -$323.0 million in Q2 2026 per DGX's latest filing, from -$93.0 million in the prior quarter.
• Over five years, Enterprise Value peaked at -$49.0 million in Q2 2023 and troughed at -$713.0 million in Q2 2022.
• A 5-year average of -$345.7 million and a median of -$331.5 million in 2025 frame the typical range for Enterprise Value.
• The sharpest annual moves came in 2023 and 2024: Enterprise Value jumped 93.13% in 2023, then plunged 920.9% in 2024.
• Over 5 years, Enterprise Value stood at -$238.0 million in 2022, then sank by 156.3% to -$610.0 million in 2023, then rose by 23.61% to -$466.0 million in 2024, then advanced by 27.04% to -$340.0 million in 2025, then gained by 5.0% to -$323.0 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$323.0 million, -$93.0 million, and -$340.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.